Specifically, oral A. muciniphila administration as a prebiotic treatment for diet-induced obesity mice not only increased Muc2 protein production to restore mucus layer thickness but also prevented the intestinal barrier from injury via decreasing high fat-induced endotoxemia (Everard et al., 2013). Here, MUC2 is linked to serum lipopolysaccharide activity.